Pfizer Shifts Focus to Cancer Drugs After Decline in Business Post-COVID-19
Pfizer Inc. is shifting its strategic focus from COVID to cancer pharmaceuticals in an effort to ...
Read moreDetails
Tag: pfizer
BioNTech acquires GMP manufacturing site to establish new mRNA vaccine facility in Singapore
BioNTech’s Singapore facility will create regional manufacturing capacities that will support BioNTech’s growing pipeline of mRNA-based ...
Read moreDetails
In new move, French vaccines company Valneva to divest 8.1 percent stake to Pfizer
Valneva, a specialty vaccine company, and Pfizer Inc announced that they have entered into an Equity ...
Read moreDetails
New Omicron Variant Causes Slump in Financial Markets in November 2021
Research is still ongoing to determine if omicron results in the same degree of illness as ...
Read moreDetails
Pfizer – The third booster vaccine of 🦠 COVID-19 combats reduced protection
The Health Ministry of Israel reported conclusions of advancement in the protection against COVID-19 infection, owing ...
Read moreDetails
S.Korea’s President Moon pledges $1.92bn to boost COVID-19 vaccine production
President Moon Jae-in said that he plans to invest (US$1.92 billion) KRW2.2 trillion to turn The ...
Read moreDetails
Variants Fuel Covid-19 Cases, Vaccine Makers on Their Toes
The highly contagious variants of the coronavirus are fuelling the surge of fresh cases of COVID-19 ...
Read moreDetails
The Global Economics Limited is a UK based financial publication and a Bi-Monthly business magazine giving thoughtful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.
